Search Results - "Roberto Augusto Caffaro MD, PhD"

Biomarkers Profile in Provoked Unprovoked Deep Venous Thrombosis by Isabela Rodrigues Tavares MD, Roberto Augusto Caffaro MD, PhD, Maria Fernanda Portugal MD, PhD, Camilla Moreira Ribeiro PhD, Viviane Santana da Silva MD, Emily Krupa MD, Srdjan Nikolovski MD, Karen Falcão de Britto MD, Ana Cláudia Gomes Pereira Petisco MD, Maria Cristina Miranda MD, Sandra Gomes de Souza Santos MD, Marcela da Silva Dourado MD, Paula Veloso Siqueira PhD, Fakiha Siddiqui PhD, Jawed Fareed PhD, Eduardo Ramacciotti MD, PhD

“…Venous thromboembolism (VTE), including deep venous thrombosis (DVT) and pulmonary embolism (PE), represents a substantial healthcare challenge. Provoked and…”
Get full text

Rivaroxaban with Aspirin Versus Aspirin for Peripheral Arterial Disease and Intermittent Claudication. Rationale and Design of the COMPASS CLAUDICATION Trial by Ramacciotti, Eduardo, Agati, Leandro Barile, Volpiani, Giuliano Giova, Brito, Karen Falcão, Ribeiro, Camilla Moreira, Aguiar, Valéria Cristina Resende, Ramacciotti, Lorenzo Storino, Paganotti, Alexia, Pereira, Felipe Menegueti, Caffaro, Roberto Augusto, Fioranelli, Alexandre, Krakauer, Rogério, Rached, Heron Rhydan Saad, Wolosker, Nelson, Anand, Sonia S., Eikelboom, John W., Lopes, Renato Delascio

“…Background The COMPASS trial demonstrated that in patients with peripheral arterial disease, the combination of rivaroxaban and aspirin compared with aspirin…”
Get full text

Comparative Studies on the Anticoagulant Profile of Branded Enoxaparin and a New Biosimilar Version by Qneibi, Dalia, Ramacciotti, Eduardo, Macedo, Ariane Scarlatelli, Caffaro, Roberto Augusto, Agati, Leandro Barile, Siddiqui, Fakiha, Kouta, Ahmed, Hoppensteadt, Debra, Fareed, Jawed, Carter, Charles A.

“…Low molecular weight heparins (LMWH) represent depolymerized heparin prepared by various methods that exhibit differential, biochemical and pharmacological…”
Get full text

Direct Oral Anticoagulants and Cancer-Associated Thrombosis Management. Where Do We Stand in 2019? by Ramacciotti, Eduardo, Agati, Leandro B., Caffaro, Roberto Augusto, Volpiani, Giuliano G., Lopes, Renato D., Comerota, Anthony J., Fareed, Jawed

“…Direct oral anticoagulants (DOACs) are now widely used for the management of venous thromboembolism (VTE) that now includes cancer-associated thrombosis. This…”
Get full text